Skip to main content

Table 2 miRNAs significantly changed between PCa patients and healthy controls. The table shows miRNAs that were significantly changed compared to healthy controls in one of more of the following groups: all patients together, PC patients with Gleason score 7a (3 + 4), PC patients with Gleason score 7b (4 + 3), PC intermediate (D’Amico criteria) and PC aggressive (D’Amico criteria). Fold change: patient versus controls. Both SAM and rank product were used as statistical analysis

From: Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes

miRNAs

Fold change

q-value

Statistics

miR-196a-5p

−2.375

<0.05

SAM

miR-34a-5p

−4.385

<0.05

SAM

miR-501-3p

−7.315

0.009

Rank Product

miR-92a-1-5p

−6.481

0.025

Rank Product

miR-143-3p

−5.086

0.028

Rank Product